ADC Therapeutics's total assets for Q3 2025 were $289.76M, a decrease of ― from the previous quarter. ADCT total liabilities were $527.94M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.